HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Casas Selected Research

alpha-latrotoxin receptor

11/2012[Genetic bases of attention deficit hyperactivity disorder].
3/2011Contribution of LPHN3 to the genetic susceptibility to ADHD in adulthood: a replication study.
11/2010A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Casas Research Topics

Disease

14Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2017 - 05/2007
4Cocaine-Related Disorders (Cocaine Addiction)
10/2015 - 01/2007
3Breast Neoplasms (Breast Cancer)
01/2022 - 01/2018
3Hypoxia (Hypoxemia)
12/2001 - 02/2000
2Mental Disorders (Mental Disorder)
01/2016 - 03/2010
2Gambling (Pathological Gambling)
01/2015 - 07/2009
2Opioid-Related Disorders (Opiate Addiction)
11/2001 - 06/2000
2Parkinson Disease (Parkinson's Disease)
06/2000 - 01/2000
1Neutropenia
01/2022
1Anemia
01/2022
1Lymphopenia (Lymphocytopenia)
01/2022
1Asthma (Bronchial Asthma)
01/2017
1Peritonitis
01/2016
1Genetic Predisposition to Disease (Genetic Predisposition)
10/2015
1Bradycardia
01/2015
1Hypotension (Low Blood Pressure)
01/2015
1Hemangioma (Angioma)
01/2015
1Psychotic Disorders (Schizoaffective Disorder)
03/2013
1Antisocial Personality Disorder (Antisocial Personality)
03/2013
1Marijuana Abuse (Cannabis Abuse)
03/2013
1Hallucinations (Hallucination)
03/2013
1Paranoid Disorders (Paranoia)
03/2013
1Attention Deficit and Disruptive Behavior Disorders (Disruptive Behavior Disorder)
06/2012
1Anxiety Disorders (Anxiety Disorder)
06/2012
1Depressive Disorder (Melancholia)
06/2012
1Stomatognathic Diseases (Dental Disease)
11/2010
1Type 3 von Willebrand Disease
11/2010
1Substance-Related Disorders (Drug Abuse)
01/2010
1Firesetting Behavior (Arson)
07/2009
1Excoriation Disorder
07/2009
1Disruptive, Impulse Control, and Conduct Disorders (Kleptomania)
07/2009
1Infections
05/2007
1Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
05/2007
1Pancreatitis
05/2007
1Kaposi Sarcoma (Kaposi's Sarcoma)
01/2005

Drug/Important Bio-Agent (IBA)

4Cocaine (Cocaine HCl)IBA
10/2015 - 01/2010
3Hormones (Hormone)IBA
01/2022 - 01/2018
3Hydrocortisone (Cortisol)FDA LinkGeneric
01/2017 - 06/2012
3alpha-latrotoxin receptorIBA
11/2012 - 11/2010
3Brain-Derived Neurotrophic Factor (BDNF)IBA
03/2010 - 01/2007
2Methylphenidate (Ritalin)FDA LinkGeneric
01/2017 - 01/2012
2MicroRNAs (MicroRNA)IBA
01/2016 - 10/2015
2AlbuminsIBA
01/2016 - 05/2007
2Serotonin (5 Hydroxytryptamine)IBA
02/2013 - 01/2009
2Nerve Growth Factors (Neurotrophins)IBA
02/2013 - 05/2007
2Pharmaceutical PreparationsIBA
11/2012 - 01/2010
2Proteins (Proteins, Gene)FDA Link
03/2010 - 05/2007
2Lactic Acid (Lactate)FDA LinkGeneric
12/2001 - 02/2000
1Fulvestrant (Faslodex)FDA Link
01/2022
1palbociclibIBA
01/2022
1human ERBB2 proteinIBA
01/2022
1Bevacizumab (Avastin)FDA Link
01/2019
1Progesterone Receptors (Progesterone Receptor)IBA
01/2018
1CytokinesIBA
01/2017
1Environmental Pollutants (Pollutants, Environmental)IBA
01/2017
1Interleukin-6 (Interleukin 6)IBA
01/2017
1Biological ProductsIBA
10/2016
1Urea (Carbamide)FDA LinkGeneric
01/2016
1Propranolol (Inderal)FDA LinkGeneric
01/2015
1Indicators and Reagents (Reagents)IBA
01/2015
1Timolol (Blocadren)FDA LinkGeneric
01/2015
1Dopamine (Intropin)FDA LinkGeneric
02/2013
1Serotonin ReceptorsIBA
02/2013
1EnzymesIBA
11/2012
1Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
11/2012
1Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
11/2012
1Cytochrome P-450 CYP2D6 (CYP2D6)IBA
11/2012
1Adrenergic Agents (Adrenergic Drugs)IBA
11/2012
1Dopamine Receptors (Dopamine Receptor)IBA
11/2012
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
03/2011
1Corticotropin-Releasing HormoneIBA
01/2010
1Explosive Agents (Explosives)IBA
07/2009
1Neurotransmitter Agents (Neurotransmitter)IBA
05/2007
1AmmoniaIBA
12/2001
1Risperidone (Risperdal Consta)FDA LinkGeneric
11/2001
1Pergolide (Permax)FDA Link
06/2000
1Dopamine Agonists (Dopamine Agonist)IBA
06/2000
1Caffeine (No Doz)FDA LinkGeneric
06/2000
1Buprenorphine (Subutex)FDA LinkGeneric
06/2000
1ErythropoietinFDA Link
06/2000
1Hemoglobins (Hemoglobin)IBA
02/2000
1Oxygen (Dioxygen)IBA
02/2000
1N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamineIBA
01/2000

Therapy/Procedure

1Therapeutics
01/2019
1Topical Administration
01/2015
1Dental Care
11/2010
1Self Administration (Administration, Self)
01/2010
1Enteral Nutrition (Feeding, Tube)
05/2007
1Length of Stay
05/2007
1Total Parenteral Nutrition
05/2007
1Renal Dialysis (Hemodialysis)
01/2005